NeuroBo Pharmaceuticals, Inc

-$0.17 (-5.25%) Today
-$0.11 (-3.58%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRBO and other ETFs, options, and stocks.

About NRBO

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline include ANA001, a proprietary oral niclosamide formulation; Gemcabene, which is assessed as an acute indication for COVID-19; NB-01, a treatment for painful diabetic neuropathy; and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.

CEO
Jeong Gu Kang
Employees
7
Headquarters
Boston, Massachusetts
Founded
2014

NRBO Key Statistics

Market Cap
68.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
13.88M
High Today
$3.38
Low Today
$2.92
Open Price
$3.38
Volume
910.55K
52 Week High
$7.61
52 Week Low
$2.70

NRBO Earnings

-$3.37
-$2.25
-$1.12
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure